Awarded the "III GAP Grant MIRAI" at Mirai 2020

iMed Technologies, Inc. (headquartered in Shibuya-ku, Tokyo; Representative Director and CEO, Kenichi Kono; Representative Director and COO, Motohisa Kaneko; hereafter iMed Technologies), which develops surgical support AI for endovascular therapy, has been awarded the “III GAP Grant MIRAI” at Mirai 2020, an incubation and acceleration program hosted by the Incubation & Innovation Initiative (hereafter III).

See the following website for details. https://mirai.ventures/2020/last_exam/

With funding support from the “III GAP Grant MIRAI,” iMed Technologies will accelerate the commercialization of its surgical support AI for endovascular therapy.

■About iMed Technologies, Inc. Under the mission of “Delivering safe surgery to the world,” iMed Technologies develops surgical support AI for ischemic stroke and subarachnoid hemorrhage.

■iMed Technologies, Inc. Company Profile Company name: iMed Technologies, Inc. Address: 5F Eclat Shibuya, 3-6-2 Shibuya, Shibuya-ku, Tokyo Founded: April 1, 2019 Business: Development of surgical support AI for ischemic stroke and subarachnoid hemorrhage Representatives: Representative Director and CEO, physician Kenichi Kono Representative Director and COO, Motohisa Kaneko